Studies have indicated that genetic variation in tau may contribute to age-related systemic amyloidosis and increase the risk of myocardial infarction (MI), suggesting a link between tau and cardiac amyloidosis. The gene discussed is MAPT; the disease is cardiac amyloidosis.